Invention Grant
- Patent Title: 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds
-
Application No.: US16782952Application Date: 2020-02-05
-
Publication No.: US11352387B2Publication Date: 2022-06-07
- Inventor: Hugh Griffith , Christopher McGuigan , Valentina Ferrari , Michaela Serpi , Carmen Jimenez Antunez
- Applicant: NuCana plc
- Applicant Address: GB Edinburgh
- Assignee: NuCana plc
- Current Assignee: NuCana plc
- Current Assignee Address: GB Edinburgh
- Agency: Knowles Intellectual Property Strategies, LLC
- Priority: GB1421211 20141128,GB1519316 20151102
- Main IPC: C07H19/20
- IPC: C07H19/20 ; C07H19/173

Abstract:
Disclosed are chemical compounds, the compounds for use in a method of treatment, particularly in a method of prophylaxis or treatment for cancer, a process for preparation of the compounds and pharmaceutical compositions comprising the compounds. The compounds may, in particular, be useful in the treatment of leukaemia, lymphoma and/or solid tumours in Homo sapiens. The compounds are derivatives of cordycepin (3′-deoxyadenosine) having a 2′ and/or 5′-amino-acid ester phosphoramidate moiety.
Public/Granted literature
- US20200181189A1 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS Public/Granted day:2020-06-11
Information query
IPC分类: